Brian A Coffman Selected Research

Psychotic Disorders (Schizoaffective Disorder)

5/2024	Development of Biomarkers Potentially Sensitive to Early Psychosis Using Mismatch Negativity (MMN) to Complex Pattern Deviations.
1/2024	A whole-brain neuromark resting-state fMRI analysis of first-episode and early psychosis: Evidence of aberrant cortical-subcortical-cerebellar functional circuitry.
8/2023	Is source-resolved magnetoencephalographic mismatch negativity a viable biomarker for early psychosis?
6/2023	White matter tracts differentially associated with auditory hallucinations in first-episode psychosis: A correlational tractography diffusion spectrum imaging study.
1/2023	Functional connectivity and gray matter deficits within the auditory attention circuit in first-episode psychosis.
1/2023	Recovery of auditory evoked response attentional gain modulation following the first psychotic episode indexes improvements in symptom severity.
1/2023	Attentional M100 gain modulation localizes to auditory sensory cortex and is deficient in first-episode psychosis.
1/2022	Pathological resting-state executive and language system perfusion in first-episode psychosis.
1/2021	White Matter Microstructural Abnormalities in the Broca's-Wernicke's-Putamen "Hoffman Hallucination Circuit" and Auditory Transcallosal Fibers in First-Episode Psychosis With Auditory Hallucinations.
1/2021	Parahippocampal area three gray matter is reduced in first-episode schizophrenia spectrum: Discovery and replication samples.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brian A Coffman Research Topics

Disease

11	Psychotic Disorders (Schizoaffective Disorder) 05/2024 - 01/2020
4	Schizophrenia (Dementia Praecox) 08/2023 - 01/2017
2	Hallucinations (Hallucination) 06/2023 - 01/2023
2	Disease Progression 11/2020 - 01/2020
2	Fetal Alcohol Spectrum Disorders 01/2020 - 10/2012
1	Paralysis (Palsy) 04/2024
1	Mental Disorders (Mental Disorder) 01/2024
1	Mania (Manias) 01/2021
1	Prodromal Symptoms 01/2020
1	Aphasia (Dysphasia) 01/2020
1	Nervous System Diseases (Neurological Disorders) 01/2015

Drug/Important Bio-Agent (IBA)

7	Polytetrafluoroethylene (Teflon)FDA Link 01/2024 - 01/2021
6	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2017
2	volociximabIBA 01/2020 - 10/2012
1	SolutionsIBA 08/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2021

Therapy/Procedure

2	Transcranial Direct Current Stimulation 01/2021 - 01/2015
1	Brain-Computer Interfaces 04/2024